HIMS
HealthcareHims & Hers Health, Inc.
$34.71
+$1.30 (+3.89%)
Jan 5, 2026
Price History (1Y)
Analysis
Hims & Hers Health, Inc. is a healthcare company listed in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company has a significant market presence with a market capitalization of $7.90B and annual revenues exceeding $2.21B. The company's financial health shows mixed results. Gross margin is high at 75.0%, indicating relatively low production costs. However, operating margins are thin at 2.1%, suggesting that the company incurs significant operational expenses. Profit margins of 6.1% suggest some ability to maintain profitability despite these costs. Return on Equity and Return on Assets stand at 26.2% and 5.6%, respectively, indicating relatively strong returns for shareholders and assets. The balance sheet shows a substantial debt-to-equity ratio of 192.44, with $1.12B in debt against $629.74M in cash. Hims & Hers Health's valuation metrics indicate a P/E ratio (TTM) of 63.11 and Forward P/E of 30.66, placing the stock at a premium compared to its earnings growth rate of -80.3% year-over-year. Revenue growth has been strong, reaching 49.2% year-over-year. The company does not pay dividends.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. The company also provides Labs which measures key markers over time and provides doctor-developed action plans. Hims & Hers Health, Inc. is based in San Francisco, California.
Visit website →Key Statistics
- Market Cap
- $7.90B
- P/E Ratio
- 63.11
- 52-Week High
- $72.98
- 52-Week Low
- $23.97
- Avg Volume
- 22.13M
- Beta
- 2.37
Company Info
- Exchange
- NYQ
- Country
- United States
- Employees
- 1,637